1. Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment. Dosoky NS, Chen Z, Guo Y, McMillan C, Flynn CR, Davies SS (2019) Appl Microbiol Biotechnol 103(16): 6711-6723
    › Primary publication · 31203417 (PubMed) · PMC7066869 (PubMed Central)
  2. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples. Yermalitsky VN, Matafonova E, Tallman K, Li Z, Zackert W, Roberts LJ, Amarnath V, Davies SS (2019) Anal Biochem : 89-101
    › Primary publication · 30458125 (PubMed)
  3. Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor Mice Improves Indices of Cardiometabolic Disease. May-Zhang LS, Chen Z, Dosoky NS, Yancey PG, Boyd KL, Hasty AH, Linton MF, Davies SS (2019) Sci Rep 9(1): 420
    › Primary publication · 30674978 (PubMed) · PMC6344515 (PubMed Central)
  4. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS (2018) J Biol Chem 293(24): 9176-9187
    › Primary publication · 29712723 (PubMed) · PMC6005447 (PubMed Central)
  5. Isolevuglandins and cardiovascular disease. Davies SS, May-Zhang LS (2018) Prostaglandins Other Lipid Mediat : 29-35
    › Primary publication · 30296489 (PubMed) · PMC6555638 (PubMed Central)
  6. Dietary Fatty Acids Control the Species of N-Acyl-Phosphatidylethanolamines Synthesized by Therapeutically Modified Bacteria in the Intestinal Tract. Dosoky NS, Guo L, Chen Z, Feigley AV, Davies SS (2018) ACS Infect Dis 4(1): 3-13
    › Primary publication · 29019649 (PubMed) · PMC6555640 (PubMed Central)
  7. Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis. Kaseda R, Tsuchida Y, Gamboa JL, Zhong J, Zhang L, Yang H, Dikalova A, Bian A, Davies S, Fogo AF, Linton MF, Brown NJ, Ikizler TA, Kon V (2018) Nutr Metab Cardiovasc Dis 28(6): 582-591
    › Primary publication · 29691148 (PubMed) · PMC5959764 (PubMed Central)
  8. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro. Longato L, Andreola F, Davies SS, Roberts JL, Fusai G, Pinzani M, Moore K, Rombouts K (2017) Free Radic Biol Med : 162-173
    › Primary publication · 27890721 (PubMed)
  9. Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases. Davies SS, Zhang LS (2017) Curr Pharmacol Rep 3(2): 51-67
    › Primary publication · 28993795 (PubMed) · PMC5630168 (PubMed Central)
  10. Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D. Chen Z, Zhang Y, Guo L, Dosoky N, de Ferra L, Peters S, Niswender KD, Davies SS (2017) J Lipid Res 58(8): 1624-1635
    › Primary publication · 28596183 (PubMed) · PMC5538284 (PubMed Central)